VESTIBULAR DYSFUNCTION AND BALANCE IMPAIRMENT IN HEAD AND NECK CANCER PATIENTS UNDERGOING CHEMOTHERAPY : A SYSTEMATIC REVIEW AND META-ANALYSIS

Khuznita Dasa Novita

Abstract


Vestibular dysfunction is an important yet underrecognized adverse effect among patients with head and neck cancer (HNC) receiving platinum-based chemotherapy. Although cochlear toxicity is well documented, evidence specifically addressing vestibular impairment in this population remains limited and methodologically variable. The novelty of this study lies in presenting the first systematic review and meta-analysis exclusively examining vestibular dysfunction in adult HNC patients receiving chemotherapy, thus establishing a more focused and consolidated evidence base. To quantify the pooled incidence, clinical features, and diagnostic patterns of vestibular dysfunction in adults with HNC undergoing chemotherapy, and to identify chemotherapeutic agents strongly associated with vestibulotoxicity . Conducted in accordance with PRISMA 2020 guidelines and prospectively registered in PROSPERO (CRD420251080552), this review regularly searched Embase, Scopus, Web of Science, and the Cochrane Library for studies published between 2014 and 2024. Eligibility criteria included adult HNC patients treated with and reporting vestibular outcomes. Risk of bias was assessed using RoB 2.0 for randomized trials and the Newcastle–Ottawa Scale for observational studies. A random-effects model was applied for quantitative synthesis. Sixteen studies met the inclusion criteria, and contributed fourteen data to the meta-analysis. The pooled incidence of vestibular dysfunction was 24.7% (95% CI: 19.2–30.8). Dizziness and imbalance were the most frequently reported symptoms, while peripheral vestibular deficits were confirmed through vHIT , VEMP, and caloric testing. Cisplatin was consistently identified as the principal chemotherapeutic agent associated with vestibulotoxicity. These findings underscore the need for standardized vestibular assessment and routine monitoring, particularly within cisplatin-based treatment regimens.

Keywords


Balance impairment; Chemotherapy; Cisplatin; Head and neck cancer; Vestibular dysfunction.

Full Text:

PDF

References


Demetriou, D., Mabongo, M., Torres-Holmes, M., Ledet, E.M., & Dlamini Z. Risk Factors in Head and Neck Cancer. Navig Head Neck Cancer Adv Diagnosis Treat. 2025;

Orasan A, Negru MC, Morgovan AI, Fleser RC, Sandu D, Sitaru AM, et al. Strategies to Mitigate Cisplatin-Induced Ototoxicity: A Literature Review of Protective Agents, Mechanisms, and Clinical Gaps. Audiol Res [Internet]. 2025 Feb 27;15(2):22. Available from: https://www.mdpi.com/2039-4349/15/2/22

Fleihan T, Nader ME, Dickman JD. Cisplatin vestibulotoxicity: a current review. Surg Front [Internet]. 2024 Oct 3;11. Available from: https://www.frontiersin.org/articles/10.3389/fsurg.2024.1437468/full

Tawalbeh M, Ibrahim RM, Al-Saraireh T, Khreesha L, Rawashdeh B Al. Intratympanic N-acetylcysteine in the prevention of cisplatin-induced ototoxicity: a systematic review and meta-analysis of randomized controlled trials. BMC Pharmacol Toxicol [Internet]. 2025 Feb 4;26(1):26. Available from: https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-024-00829-4

Sarin V, Shahi AC. Subjective Evaluation of Patients Following Treatment of Head and Neck Cancer Using Romberg Test and Activities Specific Balance Confidence Scale. Indian J Otolaryngol Head Neck Surg [Internet]. 2025 Nov 7; Available from: https://link.springer.com/10.1007/s12070-025-06186-w

Takada N, Okuda H, Shibata H, Obara N, Mori K, Terazawa K, et al. Quantitative Assessment of Vestibular Function by Video Head Impulse Test and Vestibular-Evoked Myogenic Potential During Cisplatin-Based Chemoradiation. Clin Otolaryngol. 2025 Sep;50(5):883–9.

Davidoff C, Custodio CM. Peripheral nervous system dysfunction in head and neck cancer. In: Head and Neck Cancer Rehabilitation [Internet]. Elsevier; 2025. p. 217–36. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780443118067000035

Mudhawaroh M, Ningtyas SF, Herliawati PA. Correlation Use Of Hormonal Contraception With Incidence Breast Cancer In Surgery Policlinic Rsud Jombang. Jambura J Heal Sci Res [Internet]. 2022 Feb 4;4:29–34. Available from: https://ejurnal.ung.ac.id/index.php/jjhsr/article/view/12567

Adimuntja NP, Nurdin MA, Ahmad ZF. Determinant Of Awareness Behavior In The Early Detection Effort Of Breast Cancer Among Female Students In The Public Health Faculty Of Cenderawasih University. Jambura J Heal Sci Res [Internet]. 2022 Jun 30;4(2):574–86. Available from: https://ejurnal.ung.ac.id/index.php/jjhsr/article/view/13998

Pandav R, Yadav V, Bhagat S, Sharma DK. Ototoxicity in Patients of Advanced Head and Neck Malignancies Receiving Chemoradiation Versus Radiation Alone: Comparative Study. Indian J Otolaryngol Head Neck Surg [Internet]. 2022 Dec 14;74(S3):3927–32. Available from: https://link.springer.com/10.1007/s12070-021-02754-y

Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, et al. Mechanisms of Chemotherapy-Induced Neurotoxicity. Front Pharmacol [Internet]. 2022 Mar 28;13. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2022.750507/full

Hülse R, Stuck BA, Hörmann K, Rotter N, Nguyen J, Aderhold C, et al. Changes in Vestibular Function in Patients With Head-and-Neck Cancer Undergoing Chemoradiation. Ear, Nose Throat J [Internet]. 2022 Jul 14;101(6):379–85. Available from: https://journals.sagepub.com/doi/10.1177/0145561320949482

Donovan Jacquelin, De Silva Luckshica, Cox Hayley, Palmer Gretta, Semciw Adam Ivan. Vestibular dysfunction in people who fall: A systematic review and meta-analysis of prevalence and associated factors. Clinic Rehabil. 2023 Apr;37(9):1229–47.

El Ahdab J, Vilardo M, Ong B, Thompson NR, Nero N, Günkan A, et al. The effect of vestibular rehabilitation in the management of vestibular migraine in adults: A systematic review and meta-analysis. Headache J Head Face Pain. 2025 Nov;n/a(n/a).

Moreno I, Belinchon A. Evaluating the Efficacy of Intratympanic Dexamethasone in Protecting Against Irreversible Hearing Loss in Patients on Cisplatin-Based Cancer Treatment: A Randomized Controlled Phase IIIB Clinical Trial. Ear Hear. 2022;43(2).




DOI: https://doi.org/10.37905/ijhsmr.v5i1.33558

Refbacks

  • There are currently no refbacks.


Visitor International Journal Of Health Science & Medical Research